Trends in the BVDV serological response in the upper midwest

Biologicals

Volumn 31, Issue 2, 2003, Pages 145-151

  Chase, Christopher C L ^a   Chase, Stephanie K ^a   Fawcett, Linda ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; BOVINE DIARRHEA VIRUS; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; VACCINATION; VIRUS INFECTION; VIRUS STRAIN;

ANIMALIA; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 0038627858     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1045-1056(03)00032-0     Document Type: Conference Paper

References (31)

1. Baker J.C. The clinical manifestations of bovine viral diarrhea infections. Baker J.C., Houe H. Bovine Viral Diarrhea Virus. The Veterinary Clinics of North America. 11(3):1995;425-446.
2. Murray R.D. A field investigation into causes of bovine abortion in dairy cattle. Vet Rec. 127:1990;543-547.
3. Bolin S.R. Control of bovine viral diarrhea infection by use of vaccination. Baker J.C., Houe H. Bovine Viral Diarrhea Virus. The Veterinary Clinics of North America. 11(3):1995;615-626.
4. Moerman A., Straver P.J., de Jong M.C.M., Quak J., Baanvinger T., van Oirschot J.T. Clinical consequences of bovine virus diarrhoea in a dairy herd: A longitudinal study. Veterinary Quarterly. 16:1994;115-119.
5. National Animal Health Monitoring System (NAHMS). 1994. DxMONITOR Animal Health Report. Update on bovine viral diarrhea virus. AH131. NAHMS, Animal and Plant Health Inspection Service, United States Department of Agriculture, Fort Collins, CO.
6. Van Campen H., Vorpahl P., Huzurbazar S., Edwards J., Cavender J. A case report: evidence for type 2 bovine viral diarrhea virus (BVDV)-associated disease in beef herds vaccinated with a modified-live type 1 BVDV vaccine. J Vet Diag Invest. 12:2000;263-265.
7. Carbrey E.A., Brown L.N., Chow T.L. Recommended standard laboratory techniques for diagnosing infectious bovine rhinotracheitis, bovine viral diarrhea and shipping fever (parainfluenza-3). Proceedings of the USAHA. 75:1971;629-648.
8. Bolin S.R., Ridpath J.F. Assessment of protection from systemic infection or disease afforded by low to intermediate titres of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves. AJVR. 56:1995;755-759.
9. National Animal Health Monitoring System (NAHMS). 1998. Part III: Reference of 1997 Beef Cow-calf Production Management & Disease Control. NAHMS, Animal and Plant Health Inspection Service, United States Department of Agriculture. http://www.aphis.usda.gov/vs/ceah/cahm/Beef_Cow-Calf/bf97des3.pdf .
10. National Animal Health Monitoring System (NAHMS). 1996. Part 1: Reference of 1996 Dairy Management Practices, NAHMS, Animal and Plant Health Inspection Service, United States Department of Agriculture. http://www.aphis.usda.gov/vs/ceah/cahm/Dairy_Cattle/dr96des1.pdf.
11. National Animal Health Monitoring System (NAHMS). 1995. Vaccination Practices for Respiratory Pathogens in U.S. Feedlots, NAHMS, Animal and Plant Health Inspection Service, United States Department of Agriculture. http://www.aphis.usda.gov/vs/ceah/cahm/Beef_Feedlot/cofvac.pdf.
12. National Animal Health Monitoring System (NAHMS). 2000. Vaccination of Cattle Against Respiratory Disease Pathogens in U.S. Feedlots. NAHMS, Animal and Plant Health Inspection Service, United States Department of Agriculture. http://www.aphis.usda.gov/vs/ceah/cahm/Beef_Feedlot/FD99vacc.htm.
13. Ali A.A., Salama A.A., Hurley D.J., Braun L.J., Chase C.C.L. Comparison of the cellular and humoral immune response as a predictor for protection in a type II bovine viral diarrhea virus challenge. Proceedings of the South Dakota Academy of Science. 77:1998;107.
14. AgriLaboratories. 1998. Immunogenicity of Titanium 5 L5 following BVDV 890 (type 2) challenge. Challenge Study Test Results, TR-01, AgriLabs, St. Joseph, MO.
15. AgriLaboratories. 1999a. Immunogenicity of Titanium 5 L5 following BVDV NY-1 (type 1) challenge. Challenge Study Test Results, TR-02, AgriLabs, St. Joseph, MO.
16. Boehringer Ingelheim Vetmedica. 1999. BVD vaccination and challenge trials for BVD types 1 and 2 vaccines. Technical Bulletin, TB99-107, Boehringer Ingelheim Vetmedica, St. Joseph, MO.
17. Cortese V.S., West K.H., Hassard L.E., Carmen S., Ellis J.A. Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus. JAVMA. 213:1998;1312-1319.
18. Dean H.J., Leyh R. Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine. 17:1999;1117-1124.
19. Fairbanks K, Schnackel J and Chase CCL. 2002. Cross protection with a modified live virus bovine virus diarrhea vaccine containing type 1a (Singer strain) against a type 2 890 BVDV challenge. Submitted Vet. Therapeutics.
20. Pfizer Animal Health. 2002. Separate challenge-of-immunity studies establish fetal protection claims for IBR and BVD components of Bovi-Shield FP and PregGuard FP vaccine lines. February 2002, Pfizer Inc., Lincoln NE.
21. Fort Dodge Animal Health. 1999a. Serologic responses/challenge study 168 days post vaccination. Technical Information, Fort Dodge Animal Health, September 16, 1999, Fort Dodge Animal Health, Overland Park, KS.
22. Fort Dodge Animal Health. 1999b. Challenge study one year post vaccination with a Canadian type II strain. Technical Information, Fort Dodge Animal Health, September 16, 1999, Fort Dodge Animal Health, Overland Park, KS.
23. Dubovi E.J., Grohn Y.T., Brunner M.A., Hertl J.A. Responseto modified live and killed multivalent viral vaccine in regularly vaccinated, fresh dairy cows. Vet Therapeutics. 1:2000;49-58.
24. Van Campen H., Huzurbazar S., Edwards J., Cavender J. Distribution of antibody titers to bovine viral diarrhea virus in infected, exposed and uninfected beef cattle. J Vet Diag Invest. 10:1998;183-186.
25. Marsh T., Chase C. Evaluation of alternate year vaccination practices in a cow-calf herd. AABP Proceedings. 35:2002;172.
26. Vaughn M. SN titer response comparisons among fourteen diagnostic laboratories for antibodies protecting against IBR, BVD and BRSV virus following the administration of modified live vaccine to weaning aged calves. Bovine Proceedings. 30:1997;141-143.
27. Bolin SR, Saliki JT. 1996. Serology interpretation: Bovine viral diarrhea virus (BVDV). American Association of Veterinary Laboratory Diagnosticians. http://www.aavld.org/MainMenu2/InterSerology/bovine_viral_diarrhe a.html.
28. Fulton R.W., Saliki J.T., Burge L.J., d'Offay J.M., Bolin S.R., Maes R.K., Baker J.C., Frey M.L. Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay. Clin Diag Lab Immunology. 4:1997;380-383.
29. Biocor Animal Health. 2001. Prevalence and control of BVD virus in the USA. Technical Bulletin, Vol. 1, No. 1, September 2001, Biocor Animal Health, Omaha, NE.
30. Jones L., Van Campen H., Xu Z.-C., Schnackel J.A. Comparison of neutralizing antibody titers to type 1a, 1b and 2 bovine viral diarrhea virus from experimentally infected and vaccinated cattle. Bovine Practitioner. 35:2001;137-140.
31. AgriLaboratories. 1999b. Immunogenicity of Master Guard following type 2 challenge. Challenge Study Test Results, TR-06, AgriLabs, St. Joseph, MO.